Eagle Health Investments LP
28 holdingsFiling period: 2026-06-30Current AUM: $596.4Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ARGX | Argenx SE | 76.4K | $70.9M | $66.4M | 11.14% | +81 | 2026-06-30 |
| 2 | — | Icon Pub Ltd Co | 308.1K | $53.5M | $53.5M | 8.97% | -50,357 | 2026-06-30 |
| 3 | GH | Guardant Health Inc | 300.7K | $45.1M | $52.1M | 8.73% | -9,596 | 2026-06-30 |
| 4 | INSM | Insmed Inc | 384.1K | $41.0M | $35.9M | 6.01% | +159.9K | 2026-06-30 |
| 5 | BMRN | Biomarin Pharmaceutical Inc | 624.7K | $35.7M | $34.8M | 5.84% | +118.9K | 2026-06-30 |
| 6 | ILMN | Illumina Inc | 187.4K | $33.0M | $50.8M | 8.52% | -- | 2026-06-30 |
| 7 | SRRK | Scholar Rock Hldg Corp | 555.3K | $30.5M | $23.2M | 3.88% | +61.3K | 2026-06-30 |
| 8 | PTGX | Protagonist Therapeutics Inc | 248.3K | $30.4M | $34.8M | 5.84% | +69.0K | 2026-06-30 |
| 9 | RARE | Ultragenyx Pharmaceutical in | 884.1K | $29.5M | $14.2M | 2.38% | -- | 2026-06-30 |
| 10 | CMPS | Compass Pathways PLC | 2.06M | $29.2M | $22.8M | 3.82% | -- | 2026-06-30 |
| 11 | — | Ascendis Pharma A/S | 106.2K | $28.3M | $28.3M | 4.75% | -- | 2026-06-30 |
| 12 | RVMD | Revolution Medicines Inc | 120.3K | $22.5M | $22.1M | 3.71% | +882 | 2026-06-30 |
| 13 | FTRE | Fortrea Hldgs Inc | 1.18M | $20.6M | $28.1M | 4.72% | -126,286 | 2026-06-30 |
| 14 | KYMR | Kymera Therapeutics Inc | 166.1K | $19.1M | $19.1M | 3.20% | +20.3K | 2026-06-30 |
| 15 | AXSM | Axsome Therapeutics Inc. | 65.1K | $15.9M | $9.4M | 1.57% | -- | 2026-06-30 |
| 16 | BSX | Boston Scientific Corp | 369.2K | $15.8M | $16.8M | 2.82% | +76.0K | 2026-06-30 |
| 17 | — | Alkermes PLC | 297.3K | $15.6M | $15.6M | 2.61% | +58.6K | 2026-06-30 |
| 18 | IONS | Ionis Pharmaceuticals Inc | 194.6K | $15.4M | $8.4M | 1.42% | -- | 2026-06-30 |
| 19 | TEM | Tempus AI Inc | 256.3K | $14.8M | $17.2M | 2.89% | -- | 2026-06-30 |
| 20 | DNTH | Dianthus Therapeutics Inc | 131.3K | $12.8M | $10.4M | 1.75% | -- | 2026-06-30 |
| 21 | ATAI | Ataibeckley Inc | 1.71M | $9.0M | $9.0M | 1.51% | -- | 2026-06-30 |
| 22 | ATAI | Ataibeckley Inc | 1.71M | $9.0M | $9.0M | 1.51% | -- | 2026-06-30 |
| 23 | AVTX | Avalo Therapeutics Inc | 235.1K | $4.3M | $1.6M | 0.27% | -- | 2026-06-30 |
| 24 | NTRA | Natera Inc | 15.8K | $4.3M | $6.4M | 1.08% | -106,030 | 2026-06-30 |
| 25 | LLY | Eli Lilly & Co | 2.0K | $2.4M | $2.5M | 0.43% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2